Recorded Chinese product: 氯硝西泮片氯硝西泮片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

丙胺太林是一种在国家药监局注册认定的药品。该药品含有丙胺太林-f24105fd等成分。

该药品关联的活性成分包括:丙胺太林Bingan Tailin。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:济南永宁制药股份有限公司Chinese legal name: 济南永宁制药股份有限公司。

您可以探索含有相同成分的其他药品:丙胺太林-f24105fd成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 氯硝西泮片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 丙胺太林Bingan Tailin.

Manufacturers recorded for this product: 济南永宁制药股份有限公司Chinese legal name: 济南永宁制药股份有限公司.

Explore other medicines containing the same ingredient: 丙胺太林 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 氯硝西泮片Recorded Chinese product: 氯硝西泮片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 30片30 tablets

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 济南永宁制药股份有限公司Chinese legal name: 济南永宁制药股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H37020683

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H37020683

Manufacturer

Chinese legal name: 济南永宁制药股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep tightly closed and protect from light.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H37020683

生产企业

济南永宁制药股份有限公司(国产)

适应症

胃肠痉挛性疼痛。

用法用量

成人常用量:开始用每次0.5 mg,每日3次,每3天增加0.5~1 mg,直到发作被控制或出现了不良反应为止。用量应个体化,成人最大量每日不要超过20 mg。小儿常用量:10岁或体重30kg 以下的儿童开始每日按体重0.01~0.03 mg/ kg,分2~3次服用,以后每3日增加0.25~0.5 mg,至达到按体重每日0.1~0.2 mg/ kg或出现了不良反应为止。氯硝西泮的疗程应不超过3~6个月。

不良反应

常见口干、面红、视力模糊、尿潴留、便秘、头痛、心悸等,减量或停药后可消失。

禁忌

出血性疾病及术前、尿潴留、前列腺肥大、青光眼患者及哺乳期妇女禁用。

注意事项

1.服药后24小时,症状未缓解,应立即就医。
2.心脏病、肝功能损害、高血压、呼吸道疾病等患者、孕妇及老人慎用。
3.儿童应在医师指导下使用。
4.如服用过量或出现严重不良反应,应立即就医。
5.对本品过敏者禁用,过敏体质者慎用。
6.本品性状发生改变时禁止使用。
7.请将本品放在儿童不能接触的地方。
8.儿童必须在成人监护下使用。
9.如正在使用其他药品,使用本品前请咨询医师或药师。

贮藏

密闭,遮光保存。

规格

30片

证据Evidence

  • 批准文号: 国药准字H37020683
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.